Back to top

Adicet Bio’s Promising Drug Pipeline and Buy Rating Justification

Canaccord Genuity analyst John Newman maintained a Buy rating on Adicet Bio (ACET – Research Report) yesterday and set a price target of $19.00. Jo...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Adicet Bio, Inc. (ACET)